Upregulated hypoxia-inducible factor-1 DNA binding activity to the vascular endothelial growth factor-A promoter mediates increased vascular permeability in donor lung grafts

Annals of Thoracic Surgery

Volumn 77, Issue 5, 2004, Pages 1751-1755

  Abraham, Dietmar ^a   Krenn, Katharina ^a   Seebacher, Gernot ^a   Paulus, Patrick ^a   Klepetko, Walter ^a   Aharinejad, Seyedhossein ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

12

Indexed keywords

DNA; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ARTICLE; BINDING AFFINITY; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; DOWN REGULATION; DRY WEIGHT; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG FLUID; LUNG PARENCHYMA; LUNG TRANSPLANTATION; LUNG WEIGHT; MALE; MEASUREMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; UPREGULATION; WESTERN BLOTTING;

ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BINDING SITES; BLOTTING, WESTERN; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIN-1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG TRANSPLANTATION; NUCLEAR PROTEINS; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1942532766     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.10.050     Document Type: Article

References (30)

1. Deem S., Kim J.U., Manjula B.N., et al. Effects of S-nitrosation, and cross-linking of hemoglobin on hypoxic pulmonary vasoconstriction in isolated rat lungs. Circ Res. 91:2002;626-632
2. Chen S.J., Chen Y.F., Meng Q.C., Durand J., DiCarlo V.S., Oparil S. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol. 79:1995;2122-2131
3. Morrell N.W., Morris K.G., Stenmark K.R. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol. 269:1995;H1186-1194
4. Stenmark K.R., Mecham R.P. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol. 59:1997;89-144
5. Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y., Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA. 94:1997;4273-4278
6. Flamme I., Frohlich T., von Reutern M., Kappel A., Damert A., Risau W. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1α and developmentally expressed in blood vessels. Mech Dev. 63:1997;51-60
7. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 77:1999;527-543
8. Lassus P., Turanlahti M., Heikkila P., et al. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med. 164:2001;1981-1987
9. Kazi A.A., Lee W.S., Wagner E., Becker P.M. VEGF, fetal liver kinase-1, and permeability increase during unilateral lung ischemia. Am J Physiol Lung Cell Mol Physiol. 279:2000;L460-467
10. Abraham D., Taghavi S., Riml P., et al. VEGF-A, and -C but not -B mediate increased vascular permeability in preserved lung grafts. Transplantation. 73:2002;1703-1706
11. Taghavi S., Abraham D., Riml P., et al. Co-expression of endothelin-1, and vascular endothelial growth factor mediates increased vascular permeability in lung grafts before reperfusion. J Heart Lung Transplant. 21:2002;600-603
12. Palmer L.A., Semenza G.L., Stoler M.H., Johns R.A. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol. 274:1998;L212-219
13. Pedram A., Razandi M., Hu R.M., Levin E.R. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem. 272:1997;17097-17103
14. Reichart B., Gulbins H., Meiser B.M., Kur F., Briegel J., Reichenspurner H. Improved results after heart-lung transplantation a 17-year experience. Transplantation. 75:2003;127-132
15. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159
16. Abraham D., Hofbauer R., Schäfer R., et al. Selective downregulation of VEGF-A165, VEGF-R1, and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ Res. 87:2000;644-647
17. Arcasoy S.M., Kotloff R.M. Lung transplantation. N Engl J Med. 340:1999;1081-1091
18. Semenza G.L., Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 12:1992;5447-5454
19. 2 tension. Am J Physiol. 271:1996;C1172-1180
20. Forsythe J.A., Jiang B.H., Iyer N.V., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 16:1996;4604-4613
21. Palmer L.A., Semenza G.L., Stoler M.H., Johns R.A. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol. 274:1998;L212-219
22. Wiener C.M., Booth G., Semenza G.L. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun. 225:1996;485-488
23. Yu A.Y., Frid M.G., Shimoda L.A., Wiener C.M., Stenmark K., Semenza G.L. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol. 275:1998;L818-826
24. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem. 274:1999;6519-6525
25. Salceda S., Caro J. Hypoxia-inducible factor 1alpha (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem. 272:1997;22642-22647
26. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 92:1995;5510-5514
27. Semenza G.L. HIF-1 mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol. 88:2000;1474-1480
28. Hu J., Discher D.J., Bishopric N.H., Webster K.A. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem Biophys Res Commun. 245:1998;894-899
29. Li H., Chen S.J., Chen Y.F., et al. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol. 77:1994;1451-1459
30. Spinella F., Rosano L., Di Castro V., Natali P.G., Bagnato A. Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. J Biol Chem. 277:2002;27850-27855